Pamela Smith
Family · Bakersfield, CANPI 1114221785
Payments from drug & device makers
Across 95 payments — averaging $53.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$639
- Smith+Nephew$566
- Lilly USA, LLC$546
- Organogenesis Inc.$311
- Coloplast$263
- GSK$263
- plus $2K from 24 others
What the payments were for
- Food & beverage$5,062100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 11 | $639 |
| Smith+Nephew | 24 | $566 |
| Lilly USA, LLC | 7 | $546 |
| Organogenesis Inc. | 17 | $311 |
| Coloplast | 3 | $263 |
| GSK | 3 | $263 |
| AbbVie | 4 | $206 |
| Vertex | 4 | $186 |
| Madrigal Pharmaceuticals | 1 | $135 |
| Recordati_rare_diseases_inc. | 1 | $133 |
| Convatec Inc. | 1 | $129 |
| Amgen | 1 | $125 |
| Corcept Therapeutics | 1 | $125 |
| AstraZeneca | 1 | $125 |
| Dexcom, Inc. | 1 | $124 |
| Bayer | 1 | $111 |
| Urgo Medical North America, LLC | 1 | $111 |
| Abbott | 1 | $101 |
| Avita Medical Americas, LLC | 1 | $101 |
| Si-bone, Inc. | 1 | $101 |
| KCI USA, Inc. | 1 | $82 |
| Pfizer | 1 | $82 |
| Hollister Incorporated | 1 | $79 |
| Medline Industries LP | 1 | $76 |
| Aurinia Pharma U.S., Inc. | 1 | $72 |
| Phadia US Inc. | 1 | $69 |
| W. L. Gore & Associates, Inc. | 1 | $62 |
| Biosense Webster, Inc. | 1 | $59 |
| Angiodynamics, Inc. | 1 | $58 |
| Exact Sciences | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOUNJARO$229
- Ozempic$228
- REZDIFFRA$135
- ISTURISA$133
- ESTEEM$129
- EVENITY$125
- Korlym$125
- JOURNAVX$125
- FARXIGA$125
- DEXCOM G7 GSS (161)$124
- Grafix$119
- Oasis$119
- Stravix$119
- Kerendia$111
- VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP$111
- ACTICOAT 4" X 4"$105
- ALLEVYN HEEL 10.5CM X 13.5CM CTN 5$105
- PICO$105
- RYBELSUS$105
- PURAPLY WOUND MATRIX$104
How this compares
$5,062 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 13 | $313 |
Paid to pharmacies, not to this prescriber.
Other family in Bakersfield
- Jennifer TougasBakersfield$302K
- Ashton ChaseBakersfield$86K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.